Sophia Genetics

Mutational hotspot in the SARS-CoV-2 Spike protein N-terminal domain conferring immune escape potential

Our team at SOPHiA GENETICS continues to work to help advance the efforts of SARS-CoV-2 surveillance and research. During the first stages of the pandemic, we leveraged our experience in NGS and developed a robust solution for full-genome analysis of SARS-CoV-2 to identify circulating and emerging strains. Recently, our genomic experts have worked with international partners …

Mutational hotspot in the SARS-CoV-2 Spike protein N-terminal domain conferring immune escape potential Read More »

ESHG 2021 – Virtual Conference Postponed! August 28-31, 2021

01.06.2021 We regret to announce that due to severe technical issues with the virtual platform that were brought to our attention only this week, the ESHG Executive Board has been forced to postpone the conference to August 28-31, 2021. This decision was not taken lightly, but in order to avoid disappointment for delegates, presenters and sponsors alike, and to …

ESHG 2021 – Virtual Conference Postponed! August 28-31, 2021 Read More »

PATHOLOGY UPDATE 2021 EARLY BIRD REGISTRATION CLOSES: FRIDAY 18 JUNE 2021

THE PATHOLOGY UPDATE 2021 WEBSITE CONTENT WILL BE UPDATED AS ADDITIONAL INFORMATION BECOMES AVAILABLE. PLEASE CHECK BACK HERE REGULARLY FOR UPDATES. Welcome to Pathology Update 2021: Re: Cracking the Code It is with great pleasure and heartfelt thanks that the College welcomes you to Pathology Update 2021. After the hiatus of 2020 it is especially …

PATHOLOGY UPDATE 2021 EARLY BIRD REGISTRATION CLOSES: FRIDAY 18 JUNE 2021 Read More »

Three steps forward in efficient myeloid biomarker learning

More than six people die every hour in the US from a blood cancer. Solutions can’t come fast enough for those who suffer with these cancers all around the world. Fortunately, researchers studying blood diseases have experienced rapid advances in their capabilities to develop and test effective therapies with some extremely significant advancements. READ MORE

SOPHiA GENETICS Appoints Ross Muken as Chief Financial Officer

  BOSTON and LAUSANNE, Switzerland, Feb. 11, 2021 /PRNewswire/ — SOPHiA GENETICS, a global leader in Data-Driven Medicine, has appointed Ross Muken as Chief Financial Officer (CFO). Mr. Muken brings more than 20 years of financial leadership experience with a strong focus on the medical technology and life sciences space. He joins the SOPHiA GENETICS team from Click Therapeutics where he served …

SOPHiA GENETICS Appoints Ross Muken as Chief Financial Officer Read More »

GUIDELINES FOR ACCURATE GENOTYPING OF SARS-COV-2 USING AMPLICON-BASED SEQUENCING OF CLINICAL SAMPLES

Our team at SOPHiA GENETICS has worked tirelessly over the past months to help advance the efforts of SARS-CoV-2 surveillance and research. During the first stages of the pandemic, we leveraged our experience in NGS to develop and fine-tune a robust solution to conduct full-genome analysis of SARS-CoV-2. Genotyping of the virus has been instrumental to …

GUIDELINES FOR ACCURATE GENOTYPING OF SARS-COV-2 USING AMPLICON-BASED SEQUENCING OF CLINICAL SAMPLES Read More »

SOPHIA GENETICS RAISES $110 MILLION IN OVERSUBSCRIBED NEW FUNDING ROUND

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine ·      SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader ·      Company demonstrates solidity of its business model with banks joining …

SOPHIA GENETICS RAISES $110 MILLION IN OVERSUBSCRIBED NEW FUNDING ROUND Read More »